e-learning
resources
London 2016
Sunday, 04.09.2016
Pulmonary drug delivery
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Deposition of inhaled nanoparticles, airflow obstruction and emphysema
Per Wollmer (Malmø, Sweden), Laura Aaltonen, Hanna Nicklasson, Jonas Jakobsson, Sophia Zackrisson, Jakob Löndahl, Per Wollmer
Source:
International Congress 2016 – Pulmonary drug delivery
Session:
Pulmonary drug delivery
Session type:
Thematic Poster
Number:
974
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Per Wollmer (Malmø, Sweden), Laura Aaltonen, Hanna Nicklasson, Jonas Jakobsson, Sophia Zackrisson, Jakob Löndahl, Per Wollmer. Deposition of inhaled nanoparticles, airflow obstruction and emphysema. Eur Respir J 2016; 48: Suppl. 60, 974
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Calculation of peripheral airspace dimensions from deposition of inhaled nanoparticles
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Small airway function in smokers without airway obstruction
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Small airway abnormalities in elderly asthmatics with fixed airflow obstruction vs. COPD: High-resolution CT and pulmonary functions
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Eosinophilic versus non-eosinophilic COPD cannot be distinguished by lung function nor CT determined emphysema or airway remodelling
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Double-tracer gas washout in stable asthma and COPD
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Lobar variation of emphysema impacts lung function
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015
Bronchodilator treatment response mapping in COPD using hyperpolarised gas ventilation MRI
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013
Is airflow obstruction associated with nontuberculous lesions on chest X-ray?
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016
Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Airway wall volume: Implications for the CT characterization of airway disease in smokers
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013
Hemodynamic effects of inhaled fenoterol and ipratropium in patients with obstructive pulmonary diseases
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013
Small airway dysfunction is associated to the excessive bronchoconstriction in asthma
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Association between airflow obstruction and arterial stiffness
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Do all COPD patients present irreversible airflow limitation?
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Drug particle size and lung deposition in COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept